Non-Invasive Treatment for NASH

Presenter:

Amanda Chaney, DNP, APRN, FAANP, AF-AASLD
Assistant Professor of Medicine,
Mayo Clinic College of Medicine
Jacksonville, FL


Beginning Date: 03/05/2021
Ending Date: 03/05/2022

Webcast

Webcast must be viewed in its entirety to claim credit.

Accredited by:

Supported by:

This activity is supported by an educational grant from AbbVie.

Target Audience

The on-demand presentation will target nurses, nurse practitioners and physician assistants.

Educational Objectives

  • Name three comorbidities that can be associated with non-alcoholic fatty liver disease (NAFLD).
  • State the three components of encouraging lifestyle changes when treatment obesity and NAFLD.

ANCC Accreditation:

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 0.5 contact hours may be earned for successful completion of this activity.

AANP Accreditation:

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Annenberg Center for Health Sciences and Gastroenterology and Hepatology Advanced Practice Providers. Annenberg Center for Health Sciences is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.

This program is accredited for 0.5 contact hours. Program ID #5878.

AAPA Accreditation:

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 4 AAPA Category 1 CME credits. Approval is valid from 3/05/2021 to 3/05/2022 . PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-202019.

Please note, each session is eligible for 0.5 credits.

Disclosure of Conflicts of Interest

All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All staff at the Annenberg Center for Health Sciences at Eisenhower and the Gastroenterology and Hepatology Advanced Practice Providers have no relationships to disclose.

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Faculty Disclosure

Amanda Chaney, DNP, APRN, FAANP, AF-AASLD

Advisory Board: Salix, Clinical Area: Hepatic Encephalopathy

Consultant: Mallinckrodt Pharmaceuticals, Clinical Area: Hepatorenal Syndrome

Author: Springer Publishing, Clinical Area: liver disease